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Genetic factors play amajor role in the etiology of
schizophrenia and disturbances of serotonergic
pathways have been implicated in this disorder.
The aim of the present study was to examine
genetic association between schizophrenia and
polymorphisms in the 5-HT1Da (TaqI) and 5-
HT1Db (T261G and G861C) autoreceptor genes in
ninety trios from Portugal. No association or
linkage disequilibrium was obtained between
schizophrenia and 5-HT1Da and 5-HT1Db auto-
receptor genes with both haplotype relative
risk (HRR) and transmission disequilibrium test
(TDT). Concerning 5-HT1Db autoreceptor gene,
also negative results was obtained in the analysis
of the haplotypes with transmit. Thus, our data
provide no support for the hypothesis that poly-
morphisms at 5-HT1Da (TaqI) and 5-HT1Db
(T261G and G861C) genes contributes to suscept-
ibility to schizophrenia in thePortuguese popula-
tion.  2004 Wiley-Liss, Inc.
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INTRODUCTION
Schizophrenia is a major psychiatric disorder. Data from
twin, adoption and family studies have clearly demonstrated
that genetic factors playan important role in this disease [Riley
and McGuffin, 2000]. The most common mode of transmission
of schizophrenia probably involves multiple susceptibility loci
[Baron, 2001; Prasad et al., 2002], although their number and
contribution to develop the disease, and the degree of in-
teraction between them remain unanswered.
Several lines of evidence suggest that a serotonergic dys-
function is involved in the susceptibility to schizophrenia
[Kunovac and Stahl, 1995]. Serotonin (5-HT) is involved in a
wide variety of sensory, motor, and cortical functions, being
particularly relevant in modulating the effects of dopamine
[Kapur and Remington, 1996], the first neurotransmitter
supposed to be implicated in schizophrenia [Meltzer, 1987;
Bleich et al., 1988]. To date, 5-HT receptors are classified into
sevenmain classes, 5-HT1-7, which can be further divided into
different subclasses [seeBarnes andSharp, 1999]. Themanner
in which 5-HT exerts its regulatory influence on physiological
and pathological functions of the central nervous system not
only throughmultiple interactionswith other systems, but also
through a multiplicity of 5-HT receptor subtypes [see Barnes
and Sharp, 1999]. Among many 5-HT receptors subtypes, for
example, 5-HT1D receptors are important for schizophrenia
because their major function is to control 5-HT release from
serotonergic neuron terminals (autoreceptors) in the brain
[Barnes and Sharp, 1999]. Cloning studies have revealed two
5-HT1D receptor subtypes, termed 5-HT1Da and 5-HT1Db
[Hamblin and Metcalf, 1991; Demchyshyn et al., 1992;
Weinshank et al., 1992]. The genes for these receptors have
been localized to chromosomes 1p36.3-p34.3 and 6q13, respec-
tively [Libert et al., 1991; Jin et al., 1992], and are widely
expressed in the human brain [Domenech et al., 1997; Gaster
et al., 1998], with the highest levels of receptor expression
observed in limbic regions and basal ganglia [Hamblin and
Metcalf, 1991; Demchyshyn et al., 1992; Weinshank et al.,
1992]. Considering the important role of 5-HT1Da and 5-
HT1Db receptors in the control of serotonin release [Barnes
and Sharp, 1999], mutations occurring in the serotonin auto-
receptor genes may contribute to the development of schizo-
phrenia by causing altered function of serotonergic neurons.
Therefore, polymorphisms such as the silent TaqI polymorph-
ism in the coding region of 5-HT1Da gene, the T261G
polymorphism situated in the 50-untranslated region and the
G861C polymorphism situated in the coding region of HT1Db
gene may be implicated directly or indirectly through dopami-
nergic or other systems. In addition, genetic variation might
account for interindividual differences in response to drugs
acting via serotonergic pathways. In this way, alterations in
genes coding for receptor proteins may affect their binding
affinities for neuroleptics, the efficiency of signal transduction,
or their levels of expression, whichmay in turn alter the drug’s
therapeutic action.
Several studies have reported genetic linkage between
schizophrenia and markers located on chromosomes 1 and 6
[Hovatta et al., 1999;Hwu et al., 2000; Baron, 2001; Blackwood
et al., 2001; Gurling et al., 2001]. Also, support for linkage on
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chromosome 1q21-q22 was obtained with a genome-wide scan
for schizophrenia susceptibility loci in 22 affected Canadian
families [Brzustowicz et al., 2000]. Although several linkage
studies have been performed to localize major effect suscept-
ibility genes for schizophrenia; association studies based on
linkage disequilibrium are suitable, since the genetic etiology
may be multifactorial or polygenic. Any single susceptibility
gene contributes only a small fraction to the overall risk, and
allelic variation at such genesmust be high, and can be directly
evaluated as susceptibility factors using candidate gene asso-
ciation studies [Lander, 1996; Risch and Merikangas, 1996;
Collins et al., 1997]. Thus, the best approach to detect genes for
susceptibility to schizophrenia is to study homogenous popula-
tions by usingmethods based on linkage disequilibrium,which
is a potentially powerful alternative to linkage analysis for
detection of minor effect genes possibly implicated in this
disorder.
In the present study, we investigated polymorphisms of
5-HT1Daand 5-HT1Dbautoreceptor genes for susceptibility to
schizophrenia in a Portuguese population which is considered
highly homogeneous [Schindler et al., 1999].
MATERIALS AND METHODS
Sample
Ninety probands with diagnosis of schizophrenia (58 males
and 32 females) and their parents of Portuguese-Caucasian
originwere recruited fromAzoresandMainland,Portugal. The
ascertainment criteria for the study included only one proband
with schizophrenia in each family. The age of onset ranged
between15and 50years. Local ethical committee approval and
written consent from each subject were obtained. Ascertain-
ment and diagnostic methods for the families have been
described elsewhere [Pato et al., 2000; Xu et al., 2001]. The
sample used in the present study has beenpartially included in
the analyses of other candidate genes [Schindler et al., 2002].
All probands were administered the Diagnostic Interview for
Genetics Studies (DIGS) (National Institute of Mental Health-
Molecular Genetic Iniciative, 1992) [Nurnberger et al., 1994],
Portuguese version [Azevedo et al., 1993] by a clinicianwith an
extensive training in this interview. Data from the DIGS for
each subject was compared with medical records and informa-
tion from close relatives. For each proband, the Operational
Criteria (OPCRIT) [McGuffin et al., 1991] checklist was
completed, and all were diagnosed according to DSM-IV.
Laboratory Procedures
Blood samples were collectedwith EDTAanticoagulant, and
genomic DNAwas obtained using the standardmethod [Miller
et al., 1988], with slight modifications.
5-Ht1Da Gene Polymorphism
The silent polymorphism in the coding region of the 5-Ht1Da
autoreceptor gene was determined by PCR, using the same
conditions described by Ozaki et al. [1995]. Amplification was
performed in a final volume of 25 ml, containing 150 ng genomic
DNAas template, 200mMdNTPs,0.6mMofeachprimer, 10mM
Tris-HCl (pH¼ 8.3), 1.5 mM MgCl2, and 1 U of Taq polymer-
ase(Gibco, BRL, Portugal). PCR amplification was initiated at
958C for 5 min and performed for 30 cycles, each consisting of
958C for 30 sec, 578C for 30 sec, and 728C for 40 sec. PCR
products were digested using enzyme TaqI (Biolabs,
New England). The digested fragments were separated in
3.5% agarose gel and were visualized by ethidium bromide
staining. Allele frequencies for TaqI 1 and TaqI 2 were
0.966 and 0.034, respectively.
5-HT1Db Gene Polimorphisms
Two polymorphisms in 5-HT1Db gene were examined, one
polymorphism situated in the 50-untranslated region (T261G)
and other polymorphism situated in the coding sequence
region (G861C). The polymorphism situated in the 50-untrans-
lated region was carried out by using a PCR-based restriction
analysis according to the method described by Nothen et al.
[1994], with slight modifications. Standard PCR was carried
out in a volume of 25 ml, containing 150 ng genomic DNA as
template, 200 mMdNTPs, 10 pmol of each primer, 10mMTris-
HCl (pH¼ 8.3), 1.5 mM MgCl2, 0.01% gelatine and 1 U of Taq
polymerase (Perkin Elmer Cetus, Toronto). After initial
denaturation at 948C for 5 min, 35 cycles of PCR reaction were
performed under conditions of denaturation at 948C, for 20 sec,
annealing at 618C, for 20 sec, and extension at 728C, for 30 sec.
Amplification products were digested with BsmAI restriction
enzyme (Biolabs), and separated by electrophoresis in a 3.5%
agarose gel, and visualized with ethidium bromide staining
under ultraviolet light. Allele frequencies for G261 and T261
were 0.788 and 0.212, respectively.
The polymorphism situated in the coding sequence region
was genotyped using a modified protocol of the Lappalainen
et al. [1995]. Amplification was performed in a final volume of
25 ml, containing 150 ng genomic DNA as template, 200 mM
dNTPs, 0.6 mM of each primer, 10 mM Tris-HCl (pH¼ 8.3),
1.5 mMMgCl2, and 1 U of Taq polymerase (Gibco, BRL). PCR
amplificationwas initiated at 958C for 5min and performed for
30 cycles each consisting of 958C for 30 sec, 578C for 30 sec, and
728C for 40 sec. PCR products were digested using enzyme
HincII (Biolabs). The digested fragments were separated in
3.0% agarose gel and were visualized by ethidium bromide
staining. Allele frequencies for G861 and C861 were 0.799 and
0.201, respectively.
Statistical Analysis
The association studies were performed with ninety nuclear
familieswith one affected (trios), and two strategieswere used,
the haplotype relative risk (HRR) [Terwilliger and Ott, 1992],
and the transmission disequilibrium test (TDT) [Spielman
et al., 1993; Spielman and Ewens, 1998], that are robust to
population stratification. We used the HRR and TDT to test if
the marker locus and the hypothetical disease locus were
linked or in linkage disequilibrium. The TDT-STDT programe
v 1.1 uses data from heterozygous parents only, and test for
individual markers. Furthermore, multiple marker haplotype
transmission was performed with program TRANSMIT v
2.5 [Clayton, 1999]. The program TRANSMIT tests for asso-
ciation betweenmarkers anddisease, examining the transmis-
sion of multilocus haplotypes.
RESULTS
In this study, ninety nuclear families (90 Portuguese
schizophrenic patients and their parents) were used. Associa-
tion studies using case-control approach can generate false
positives as a result of population stratification. Indeed, it is
difficult to precisely match patients and controls for ethnicity,
anddifferences in allele frequencies betweenpopulations could
be generating false association. Thus, an elegant and powerful
strategy for overcoming this problem is to use the parents of
probands and we used the HRR and the TDTmethods to test if
the marker locus and the hypothetical disease locus were
linked or in linkage disequilibrium. The results of HRR and
TDT designs of the TaqI polymorphism of the HT1Da gene in
the schizophrenic trios are given in Table I. Using these
strategies, we found no evidence for association or linkage
disequilibrium between the 5-HT1Da gene (HRR, w2¼ 0.988,
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df¼ 1, P¼ 0.320; TDT, w2¼ 1.923, df¼ 1, P¼ 0.166) and
schizophrenia.
The T261G and G861C polymorphisms in the 50-untrans-
lated and coding regions, respectively, at the 5-HT1Db were
investigated and the results of HRR and TDT analysis for the
RFLPs markers individually are shown in Table II. Using the
HRR design, no significant differences were observed between
passed and non-passed alleles for both polymorphisms of the 5-
HT1Db gene (HRR of the T261G variant, w2¼ 0.000, df¼ 1,
P¼ 1.000;HRRofG861Cvariant, w2¼ 0.264, df¼ 1,P¼ 0.607).
Similarly, TDT analysis yielded non-significant P-values for
association of 5-Ht1Db polymorphisms and schizophrenia
(TDT of the T261G variant, w2¼ 0.333, df¼ 1, P¼ 0.56; TDT
of G861C variant, w2¼ 0.040, df¼ 1, P¼ 0.841; see Table II).
In addition with TRANSMIT, we estimated the haplotype
frequencies of the twomarkers in the 5-Ht1Db gene, and a total
of four haplotypes were detected, with one common haplotype
of 65.5% (Table III). Also with TRANSMIT, we analyzed
haplotypes of pairedmarkers for transmission disequilibrium,
and the results indicated no evidence for linkage disequili-
brium (Table III).
DISCUSSION
The serotonergic system, which is thought to mediate
various physiological and psychological conditions related to
certain disease state, including eating disorders, obsessive
compulsive disorders, bipolar disorder, and schizophrenia, has
been the subject of much research in psychiatric genetics.
Because for schizophrenia, 5-HT function could be particularly
important in modulating the effects of dopamine, we have
chosen a candidate gene from serotonergic system for search
schizophrenia susceptibility genes. Using association studies,
we have found no evidence for association or linkage disequili-
brium of the polymorphism at the 5-HT1Da to schizophrenia.
These results obtained with two powerful strategies of
association (HRRandTDT) indicate that aTaqI polymorphism
in the 5-HT1Da gene is unlikely to be involved in schizo-
phrenia, in our sample, although association in case-controls
from Portuguese population has been reported [Coelho et al.,
1997]. However, association studies with case-controls can
generate false positives as a result of population stratification.
This problem can be addressed by the use of nuclear families
(trios) based association methods [Ott, 1989; Terwilliger and
Ott, 1992; Schaid and Sommer, 1994], which we used in the
present work. Similarly, no evidence for association or linkage
disequilibrium was found at the individual alleles or their
haplotypes of the polymorphisms in 50-untranslated and
coding regions of the 5-HT1Db gene and schizophrenia. Our
findings are in agreement with case-controls association study
in the Portuguese population [Coelho et al., 1997] and linkage
study in the Canadian population [Sidenberg et al., 1993].
However, the present results disagree with previous reports
that provided evidence supporting linkage in chromosomal
regions of the chromosome 6 in other populations [Martinez
et al., 1999; Hwu et al., 2000; Baron, 2001]. The differences
between these studies reflect heterogeneity and that the 6p
locus could be more important in some geographical popula-
tions. There might be a gene on chromosome 6 in which
mutations increased the risk of schizophrenia in other popu-
lations, but not in the Portuguese population. The discrepancy
of the results reflects the importance of the use of more
homogeneous populations. The size of this sample was small,
which is a limitation of this work. However, family-based
association studies are more robust than traditional case-
control association analysis, as the latter often results in
spurious findings due to ethnic stratification. This was the
reason why we opted for a family-based association study,
which may render the collection of suitable samples more
difficult, but is robust against ethnic stratification. Parental
chromosomes not transmitted to affected individuals are an
ideal control group, because they are the same ethnic origin as
the affected individual alleles. Overall, the results of the
association studies employed here provide some assurance to
exclude amain involvement of the two polymorphisms at the 5-
HT1Db gene in the etiology of schizophrenia, in our sample.
However, failure to detect association or linkage disequili-
brium between the two polymorphisms in this gene cannot
exclude the possibility that there might be another mutations
in this gene that play a role in schizophrenia. In addition, it
is still also possible that the interaction with other genes is
more relevant. Indeed, serotonin has a direct influence on
the cholinergic and gabaergic system, and some of serotonin
effects on the dopamine system may be mediated, indirectly,
through itsmodulation of the gabaergic and cholinergic system
[Powers, 1999]. Future studies should determine whether
these variants are associated with other disease phenotypes
and/or are of pharmacogenetic relevance. The ability to sub-
divide the syndrome into more homogenous clinical subtypes
will help in identifying etiological factors.DNA typing together
TABLE I. HRR and TDT Results for Taql Polymorphism of
5-HT1Da in Schizophrenic Trios
5-HT1Da gene
Passed
Not
passed w2 (df¼1), P-value
HRR Allele 1 174 169 w2¼0.988, P¼0.320
Allele 2 6 11
TDT Allele 1 9 4 w2¼1.923, P¼0.166
Allele 2 4 9
TABLE II. HRR and TDT Results for G261T and G861C
Polymorphisms of 5-HT1Db in Schizophrenic Trios
5-HT1Db gene
Passed
Not
passed w2 (df¼1), P-value
HRR (1) G261 142 143 w2¼0.000, P¼ 1.000
T261 38 37
(2) G861 144 139 w2¼0.264, P¼ 0.607
C861 36 41
TDT (1) G261 7 5 w2¼0.333, P¼ 0.563
T261 5 7
(2) G861 13 12 w2¼0.040, P¼ 0.841
C861 12 13
TABLE III. Estimated Haplotype Probabilities and Transmission
of Multi-Marker Haplotypes at the 5-HT1Db Gene
Using TRANSMIT
Haplotypes Obs Exp O-E Frequency
Haplotypic
P-value
1-1 121 118 14 0.655 0.423
2-1 21 24.5 10.75 0.136 0.286
1-2 23 23.5 7.75 0.130 0.858
2-2 15 14 5.5 0.077 0.671
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with cognitive, phenomenological and neuropsychological
criteria may define more homogenous subtypes.
In conclusion, we find no support in our family-based
association study for a role of the investigated 5-HT1Da and
5-HT1Db polymorphism genes in susceptibility to schizophre-
nia in the Portuguese population.
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